Three-year data bolster use of the BeGraft as a bridging stent in FEVAR

This advertorial is sponsored by Bentley. Stéphan Haulon (Hôpital Marie Lannelongue, GHPSJ, Paris, France) has extensive clinical experience using the BeGraft (Bentley, Hechingen, Germany) as a bridging stent in fenestrated endovascular aneurysm repair (FEVAR) procedures. He has conducted a pioneering study on the topic, with the latest published data pointing to excellent patency out to three […]

The post Three-year data bolster use of the BeGraft as a bridging stent in FEVAR appeared first on Vascular News.

Vascular News’ top 10 most popular stories of September 2022

September’s top 10 highlights a randomised trial that aims to examine early endovascular aneurysm repair (EVAR) in women, new radiation safety guidelines from the European Society for Vascular Surgery (ESVS), and the latest data from renal denervation trials, among various other updates from the vascular surgery world. 1. WARRIORS randomised trial aims to examine early […]

The post Vascular News’ top 10 most popular stories of September 2022 appeared first on Vascular News.

First patient treated in the BeGraft FEVAR study aimed at providing evidence for on-label use

On 19 March, the first patient was included in the BeGraft fenestrated endovascular aneurysm repair (FEVAR) study investigating the Bentley BeGraft peripheral balloon expandable covered stent in complex aortic aneurysms. The patient was referred for FEVAR with a 6cm juxtarenal abdominal aortic aneurysm, explained the coordinating investigator and study lead, Eric Verhoeven (General Hospital Nuremberg, […]

The post First patient treated in the BeGraft FEVAR study aimed at providing evidence for on-label use appeared first on Vascular News.